During the past decade, Dres.Andreas Ammon und Dirk Meyer conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 2 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Dres.Andreas Ammon und Dirk Meyer" #1 collaborator was "Roche Pharma AG" with 2 trials as a collaborator and "Bristol-Myers Squibb" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Dres.Andreas Ammon und Dirk Meyer" are "Advanced (Locally Advanced and Inoperable or Metastatic), PD-L1 IC-positive TNBC" (1 trials), "Advanced Solid Tumors or Hematologic Malignancies" (1 trials), "Breast Cancer" (1 trials), "Chronic Lymphocytic Leukemia" (1 trials) and "Estrogen Receptor-Positive, HER2-Negative Locally Advanced or Metastatic Breast Cancer" (1 trials). Many other conditions were trialed in "Dres.Andreas Ammon und Dirk Meyer" in a lesser frequency.

Most popular intervention types in "Dres.Andreas Ammon und Dirk Meyer" are "Drug" (3 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Cyclophosphamide" (2 trials), "5-Fluorouracil" (1 trials), "Bendamustine" (1 trials), "Chlorambucil" (1 trials) and "Docetaxel" (1 trials). Other intervention names were less common.

The vast majority of trials in "Dres.Andreas Ammon und Dirk Meyer" are 5 trials for "All" genders.

Currently, there are NaN active trials in "Dres.Andreas Ammon und Dirk Meyer". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Dres.Andreas Ammon und Dirk Meyer, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Dres.Andreas Ammon und Dirk Meyer, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".